☰

Ed Reznik, Ph.D. - Publications

Affiliations: 
2013 Biomedical Engineering Boston University, Boston, MA, United States 
Area:
Biomedical Engineering, Applied Mathematics
Tree Info Similar researchers PubMed Report error

63 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Mahmood M, Liu EM, Shergold AL, Tolla E, Tait-Mulder J, Huerta-Uribe A, Shokry E, Young AL, Lilla S, Kim M, Park T, Boscenco S, Manchon JL, Rodríguez-Antona C, Walters RC, ... ... Reznik E, et al. Mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade response in melanoma. Nature Cancer. PMID 38286828 DOI: 10.1038/s43018-023-00721-w  0.306
2023 Benedetti E, Liu EM, Tang C, Kuo F, Buyukozkan M, Park T, Park J, Correa F, Hakimi AA, Intlekofer AM, Krumsiek J, Reznik E. A multimodal atlas of tumour metabolism reveals the architecture of gene-metabolite covariation. Nature Metabolism. PMID 37337120 DOI: 10.1038/s42255-023-00817-8  0.328
2023 Mahmood M, Liu EM, Shergold AL, Tolla E, Tait-Mulder J, Uribe AH, Shokry E, Young AL, Lilla S, Kim M, Park T, Manchon JL, Rodríguez-Antona C, Walters RC, Springett RJ, ... ... Reznik E, et al. Tumour mitochondrial DNA mutations drive aerobic glycolysis to enhance checkpoint blockade. Biorxiv : the Preprint Server For Biology. PMID 36993533 DOI: 10.1101/2023.03.21.533091  0.304
2022 Kim M, Mahmood M, Reznik E, Gammage PA. Mitochondrial DNA is a major source of driver mutations in cancer. Trends in Cancer. PMID 36041967 DOI: 10.1016/j.trecan.2022.08.001  0.311
2020 Hakimi AA, Attalla K, DiNatale RG, Ostrovnaya I, Flynn J, Blum KA, Ged Y, Hoen D, Kendall SM, Reznik E, Bowman A, Hwee J, Fong CJ, Kuo F, Voss MH, et al. A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response. Nature Communications. 11: 4168. PMID 32820162 DOI: 10.1038/S41467-020-17965-0  0.358
2020 Gorelick AN, Sánchez-Rivera FJ, Cai Y, Bielski CM, Biederstedt E, Jonsson P, Richards AL, Vasan N, Penson AV, Friedman ND, Ho YJ, Baslan T, Bandlamudi C, Scaltriti M, Schultz N, ... ... Reznik E, et al. Phase and context shape the function of composite oncogenic mutations. Nature. PMID 32461694 DOI: 10.1038/S41586-020-2315-8  0.354
2020 Marcon J, DiNatale RG, Sanchez A, Kotecha RR, Gupta S, Kuo F, Makarov V, Sandhu A, Mano R, Silagy AW, Blum KA, Nassau DE, Benfante NE, Ortiz MV, Carlo MI, ... ... Reznik E, et al. Comprehensive genomic analysis of translocation renal cell carcinoma reveals copy number variations as drivers of disease progression. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32220885 DOI: 10.1158/1078-0432.Ccr-19-3283  0.364
2020 Vasan N, Razavi P, Johnson JL, Shao H, Wilson T, Schimmoller F, Shah H, Antoine A, Ladewig E, Gorelick A, Lin T, Toska E, Xu G, Kazmi A, Chang MT, ... ... Reznik E, et al. Abstract P3-03-01: Double PIK3CA mutations in cis drive oncogene addiction and enhance sensitivity to PI3K alpha inhibitors in breast cancer Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P3-03-01  0.357
2019 DiNatale RG, Gorelick AN, Makarov V, Blum KA, Silagy AW, Freeman B, Chowell D, Marcon J, Mano R, Sanchez A, Attalla K, Weng S, Voss M, Motzer RJ, Russo P, ... ... Reznik E, et al. Putative Drivers of Aggressiveness in TCEB1-mutant Renal Cell Carcinoma: An Emerging Entity with Variable Clinical Course. European Urology Focus. PMID 31813809 DOI: 10.1016/J.Euf.2019.11.013  0.341
2019 DiNatale RG, Xie W, Becerra MF, Silagy AW, Attalla K, Sanchez A, Mano R, Marcon J, Blum KA, Benfante NE, Voss MH, Motzer RJ, Coleman J, Choueiri TK, Reznik E, et al. The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy. European Urology Oncology. PMID 31735646 DOI: 10.1016/J.Euo.2019.10.002  0.317
2019 Vasan N, Razavi P, Johnson JL, Shao H, Shah H, Antoine A, Ladewig E, Gorelick A, Lin TY, Toska E, Xu G, Kazmi A, Chang MT, Taylor BS, Dickler MN, ... ... Reznik E, et al. Double mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors. Science (New York, N.Y.). 366: 714-723. PMID 31699932 DOI: 10.1126/Science.Aaw9032  0.355
2019 Granlund KL, Tee SS, Vargas HA, Lyashchenko SK, Reznik E, Fine S, Laudone V, Eastham JA, Touijer KA, Reuter VE, Gonen M, Sosa RE, Nicholson D, Guo YW, Chen AP, et al. Hyperpolarized MRI of Human Prostate Cancer Reveals Increased Lactate with Tumor Grade Driven by Monocarboxylate Transporter 1. Cell Metabolism. PMID 31564440 DOI: 10.1016/J.Cmet.2019.08.024  0.372
2019 DiNatale RG, Sanchez A, Hakimi AA, Reznik E. Metabolomics informs common patterns of molecular dysfunction across histologies of renal cell carcinoma. Urologic Oncology. PMID 31155438 DOI: 10.1016/J.Urolonc.2019.04.028  0.472
2019 Xu J, Reznik E, Lee HJ, Gundem G, Jonsson P, Sarungbam J, Bialik A, Sanchez-Vega F, Creighton CJ, Hoekstra JG, Zhang L, Sajjakulnukit P, Kremer D, Tolstyka ZP, Casuscelli J, et al. Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma. Elife. 8. PMID 30924768 DOI: 10.7554/Elife.38986  0.545
2019 Xu J, Reznik E, Lee H, Gundem G, Jonsson P, Sarungbam J, Bialik A, Sanchez-Vega F, Creighton CJ, Hoekstra J, Zhang L, Sajjakulnukit P, Kremer D, Tolstyka Z, Casuscelli J, et al. Author response: Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma Elife. DOI: 10.7554/Elife.38986.025  0.54
2019 Vasan N, Razavi P, Johnson J, Shao H, Shah H, Antoine A, Ladewig E, Gorelick A, Toska E, Xu G, Kazmi A, Chang MT, Taylor BS, Dickler MN, Jhaveri K, ... ... Reznik E, et al. Abstract 3917: DoublePIK3CAmutations incisenhance oncogene activation and sensitivity to PI3K alpha inhibitors in breast cancer Cancer Research. 79: 3917-3917. DOI: 10.1158/1538-7445.Am2019-3917  0.366
2019 Vasan N, Razavi P, Johnson J, Shao H, Reznik E, Smith M, Sebra R, Cantley L, Scaltriti M, Baselga J. Double PIK3CA mutations in cis enhance PI3Kα oncogene activation and sensitivity to PI3Kα inhibitors in breast cancer Annals of Oncology. 30: iii1. DOI: 10.1093/Annonc/Mdz095  0.302
2018 Harding JJ, Lowery MA, Shih AH, Schvartzman JM, Hou S, Famulare C, Patel M, Roshal M, Do RK, Zehir A, You D, Selcuklu SD, Viale A, Tallman MS, Hyman DM, ... Reznik E, et al. Isoform switching as a mechanism of acquired resistance to mutant isocitrate dehydrogenase inhibition. Cancer Discovery. PMID 30355724 DOI: 10.1158/2159-8290.Cd-18-0877  0.308
2018 Ganly I, Makarov V, Deraje S, Dong Y, Reznik E, Seshan V, Nanjangud G, Eng S, Bose P, Kuo F, Morris LGT, Landa I, Carrillo Albornoz PB, Riaz N, Nikiforov YE, et al. Integrated Genomic Analysis of Hürthle Cell Cancer Reveals Oncogenic Drivers, Recurrent Mitochondrial Mutations, and Unique Chromosomal Landscapes. Cancer Cell. 34: 256-270.e5. PMID 30107176 DOI: 10.1016/J.Ccell.2018.07.002  0.377
2018 Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, et al. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Reports. 23: 3698. PMID 29925010 DOI: 10.1016/J.Celrep.2018.06.032  0.32
2018 Priolo C, Khabibullin D, Reznik E, Filippakis H, Ogórek B, Kavanagh TR, Nijmeh J, Herbert ZT, Asara JM, Kwiatkowski DJ, Wu CL, Henske EP. Impairment of gamma-glutamyl transferase 1 activity in the metabolic pathogenesis of chromophobe renal cell carcinoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 29891694 DOI: 10.1073/Pnas.1710849115  0.423
2018 Turajlic S, Xu H, Litchfield K, Rowan A, Chambers T, Lopez JI, Nicol D, O'Brien T, Larkin J, Horswell S, Stares M, Au L, Jamal-Hanjani M, Challacombe B, Chandra A, ... ... Reznik E, et al. Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal. Cell. PMID 29656895 DOI: 10.1016/J.Cell.2018.03.057  0.335
2018 Ricketts CJ, De Cubas AA, Fan H, Smith CC, Lang M, Reznik E, Bowlby R, Gibb EA, Akbani R, Beroukhim R, Bottaro DP, Choueiri TK, Gibbs RA, Godwin AK, Haake S, et al. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Reports. 23: 313-326.e5. PMID 29617669 DOI: 10.1016/J.Celrep.2018.03.075  0.456
2018 Armenia J, Wankowicz SAM, Liu D, Gao J, Kundra R, Reznik E, Chatila WK, Chakravarty D, Han GC, Coleman I, Montgomery B, Pritchard C, Morrissey C, Barbieri CE, Beltran H, et al. The long tail of oncogenic drivers in prostate cancer. Nature Genetics. PMID 29610475 DOI: 10.1038/S41588-018-0078-Z  0.355
2018 Reznik E, Luna A, Aksoy BA, Liu EM, La K, Ostrovnaya I, Creighton CJ, Hakimi AA, Sander C. A Landscape of Metabolic Variation across Tumor Types. Cell Systems. PMID 29396322 DOI: 10.1016/J.Cels.2017.12.014  0.735
2018 Gorelick AN, Reznik E, Cai Y, Bielski C, Bandlamudi C, Penson A, Jonsson P, La K, Scaltriti M, Schultz N, Taylor BS. Abstract 5355: Multiple mutations to the same gene are selected for and cooperate to drive cancer Cancer Research. 78: 5355-5355. DOI: 10.1158/1538-7445.Am2018-5355  0.378
2018 Dong Y, Ganly I, Makarov V, Kuo F, Deraje S, Reznik E, Seshan V, Nanjangud G, Morris L, Riaz N, Sherman E, Ghossein R, Fagin J, Chan T. Abstract 4619: Integrated genomic analysis of Hurthle cell carcinoma reveals TMEM233/PRKAB1 fusion as a novel oncogenic driver Cancer Research. 78: 4619-4619. DOI: 10.1158/1538-7445.Am2018-4619  0.369
2018 Sanchez-Vega F, Chatila WK, Ganesh K, Penson A, Camacho N, Jonsson P, Reznik E, Gao J, Yaeger R, Berger MF, Taylor BS, Schultz N. Abstract 3024: Genomic characterization of organ-specific metastasis from prospective clinical sequencing of 20,000 cancer patients Cancer Research. 78: 3024-3024. DOI: 10.1158/1538-7445.Am2018-3024  0.372
2018 Nassau DE, Sanchez A, Dinatale R, Blum KA, Ghanaat M, Gupta S, Arcila ME, Voss MH, Motzer RJ, Russo P, Coleman J, Reznik E, Reuter V, Hakimi AA. MP28-08 CLINICOPATHOLOGIC AND GENOMIC EVALUATION OF TRANSLOCATION RENAL CELL CARCINOMA Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.908  0.319
2017 Becerra MF, Reznik E, Redzematovic A, Tennenbaum DM, Kashan M, Ghanaat M, Casuscelli J, Manley B, Jonsson P, DiNatale RG, Blum KA, Durack JC, Solomon SB, Arcila ME, Bourque C, et al. Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma. European Urology Focus. PMID 29066084 DOI: 10.1016/J.Euf.2017.09.016  0.345
2017 Casuscelli J, Becerra MF, Manley BJ, Zabor EC, Reznik E, Redzematovic A, Arcila ME, Tennenbaum DM, Ghanaat M, Kashan M, Stief CG, Carlo M, Voss MH, Feldman DR, Motzer RJ, et al. Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma. European Urology Focus. PMID 28951115 DOI: 10.1016/J.Euf.2017.09.008  0.35
2017 Reznik E, Christodoulou D, Goldford JE, Briars E, Sauer U, Segrè D, Noor E. Genome-Scale Architecture of Small Molecule Regulatory Networks and the Fundamental Trade-Off between Regulation and Enzymatic Activity. Cell Reports. 20: 2666-2677. PMID 28903046 DOI: 10.1016/J.Celrep.2017.08.066  0.734
2017 Rosenzweig B, Rubinstein ND, Reznik E, Shingarev R, Juluru K, Akin O, Hsieh JJ, Jaimes EA, Russo P, Susztak K, Coleman JA, Hakimi AA. Benign and tumor parenchyma metabolomic profiles affect compensatory renal growth in renal cell carcinoma surgical patients. Plos One. 12: e0180350. PMID 28727768 DOI: 10.1371/Journal.Pone.0180350  0.318
2017 Farshidfar F, Zheng S, Gingras MC, Newton Y, Shih J, Robertson AG, Hinoue T, Hoadley KA, Gibb EA, Roszik J, Covington KR, Wu CC, Shinbrot E, Stransky N, Hegde A, ... ... Reznik E, et al. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. Cell Reports. 19: 2878-2880. PMID 28658632 DOI: 10.1016/J.Celrep.2017.06.008  0.502
2017 Farshidfar F, Zheng S, Gingras MC, Newton Y, Shih J, Robertson AG, Hinoue T, Hoadley KA, Gibb EA, Roszik J, Covington KR, Wu CC, Shinbrot E, Stransky N, Hegde A, ... ... Reznik E, et al. Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles. Cell Reports. 18: 2780-2794. PMID 28297679 DOI: 10.1016/J.Celrep.2017.02.033  0.539
2017 Barenholz U, Davidi D, Reznik E, Bar-On Y, Antonovsky N, Noor E, Milo R. Design principles of autocatalytic cycles constrain enzyme kinetics and force low substrate saturation at flux branch points. Elife. 6. PMID 28169831 DOI: 10.7554/Elife.20667  0.387
2017 Reznik E, Wang Q, La K, Schultz N, Sander C. Mitochondrial respiratory gene expression is suppressed in many cancers. Elife. 6. PMID 28099114 DOI: 10.7554/Elife.21592  0.525
2017 Rosenzweig B, Rubinstein ND, Reznik E, Zareba P, Shingarev R, Juluru K, Akin O, Hsieh JJ, Jaimes E, Russo P, Susztak K, Coleman JA, Hakimi AA. MP73-17 BENIGN AND TUMOR PARENCHYMA METABOLOMIC PROFILES AFFECT COMPENSATORY RENAL GROWTH IN RENAL CELL CARCINOMA SURGICAL PATIENTS Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.3362  0.327
2017 Becerra M, Sanchez-Vega F, Reznik E, Manley B, Kashan M, Ghanaat M, Casuscelli J, Redzematovic A, Mendonca S, Arcila M, Coleman J, Russo P, Hsieh J, Hakimi AA. MP39-03 IMPACT OF SOMATIC MUTATIONS ON PATTERNS OF METASTASIS IN CLEAR CELL RENAL CELL CARCINOMA Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1177  0.334
2017 Becerra M, Reznik E, Tennenbaum D, Kashan M, Ghanaat M, Casuscelli J, Manley B, Redzematovic A, Mendonca S, Arcila M, Coleman J, Russo P, Hsieh J, Hakimi AA. MP39-02 COMPARATIVE GENOMIC PROFILING OF MATCHED PRIMARY AND METASTATIC TUMORS IN RENAL CELL CARCINOMA Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1176  0.352
2017 Manley B, Reznik E, Becerra M, Casuscelli J, Tennenbaum D, Ghanaat M, Kashan M, Redzematovic A, Sato Y, Arcila M, Voss M, Feldman D, Russo P, Coleman J, Hsieh J, et al. MP39-01 CHARACTERIZING RECURRENT AND LETHAL SMALL RENAL MASSES IN CLEAR CELL RENAL CELL CARCINOMA USING SOMATIC MUTATIONS Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1175  0.328
2016 Dong Y, Manley BJ, Becerra MF, Redzematovic A, Casuscelli J, Tennenbaum DM, Reznik E, Han S, Benfante N, Chen YB, Arcila ME, Aras O, Voss MH, Feldman DR, Motzer RJ, et al. Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples. European Urology Focus. PMID 28753786 DOI: 10.1016/J.Euf.2016.08.005  0.309
2016 Zhao Q, Stettner AI, Reznik E, Paschalidis ICh, Segrè D. Mapping the landscape of metabolic goals of a cell. Genome Biology. 17: 109. PMID 27215445 DOI: 10.1186/S13059-016-0968-2  0.652
2016 Chen F, Zhang Y, Şenbabaoğlu Y, Ciriello G, Yang L, Reznik E, Shuch B, Micevic G, De Velasco G, Shinbrot E, Noble MS, Lu Y, Covington KR, Xi L, Drummond JA, et al. Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma. Cell Reports. PMID 26947078 DOI: 10.1016/J.Celrep.2016.02.024  0.543
2016 Reznik E, Miller ML, Şenbabaoğlu Y, Riaz N, Sarungbam J, Tickoo SK, Al-Ahmadie HA, Lee W, Seshan VE, Hakimi AA, Sander C. Mitochondrial DNA copy number variation across human cancers. Elife. 5. PMID 26901439 DOI: 10.7554/Elife.10769  0.547
2016 Hakimi AA, Reznik E, Lee CH, Creighton CJ, Brannon AR, Luna A, Aksoy BA, Liu EM, Shen R, Lee W, Chen Y, Stirdivant SM, Russo P, Chen YB, Tickoo SK, et al. An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma. Cancer Cell. 29: 104-116. PMID 26766592 DOI: 10.1016/J.Ccell.2015.12.004  0.737
2016 Reznik E, Wang Q, La K, Schultz N, Sander C. Author response: Mitochondrial respiratory gene expression is suppressed in many cancers Elife. DOI: 10.7554/Elife.21592.018  0.482
2016 Rosenzweig B, Reznik E, Shingarev R, Zabor EC, Stirdivant S, Sander C, Hsieh JJ, Jaimes EA, Russo P, Hakimi AA, Coleman JA. MP85-20 METABOLOMICS AND POST-NEPHRECTOMY RENAL FUNCTION PREDICTION Journal of Urology. 195. DOI: 10.1016/J.Juro.2016.02.2286  0.46
2015 Miller ML, Reznik E, Gauthier NP, Aksoy BA, Korkut A, Gao J, Ciriello G, Schultz N, Sander C. Pan-Cancer Analysis of Mutation Hotspots in Protein Domains. Cell Systems. 1: 197-209. PMID 27135912 DOI: 10.1016/J.Cels.2015.08.014  0.735
2015 Gauthier NP, Reznik E, Gao J, Sumer SO, Schultz N, Sander C, Miller ML. MutationAligner: a resource of recurrent mutation hotspots in protein domains in cancer. Nucleic Acids Research. PMID 26590264 DOI: 10.1093/Nar/Gkv1132  0.544
2015 Linehan WM, Spellman PT, Ricketts CJ, Creighton CJ, Fei SS, Davis C, Wheeler DA, Murray BA, Schmidt L, Vocke CD, Peto M, Al Mamun AA, Shinbrot E, Sethi A, Brooks S, ... ... Reznik E, et al. Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. The New England Journal of Medicine. PMID 26536169 DOI: 10.1056/Nejmoa1505917  0.338
2015 Sandhu R, Georgiou T, Reznik E, Zhu L, Kolesov I, Senbabaoglu Y, Tannenbaum A. Graph Curvature for Differentiating Cancer Networks. Scientific Reports. 5: 12323. PMID 26169480 DOI: 10.1038/Srep12323  0.307
2015 Reznik E, Sander C. Extensive decoupling of metabolic genes in cancer. Plos Computational Biology. 11: e1004176. PMID 25961905 DOI: 10.1371/Journal.Pcbi.1004176  0.59
2015 Reznik E, Miller ML, Şenbabaoğlu Y, Riaz N, Sarungbam J, Tickoo SK, Al-Ahmadie HA, Lee W, Seshan VE, Hakimi AA, Sander C. Author response: Mitochondrial DNA copy number variation across human cancers Elife. DOI: 10.7554/Elife.10769.028  0.466
2015 Miller ML, Reznik E, Gauthier NP, Aksoy BA, Korkut A, Gao J, Ciriello G, Schultz N, Sander C. Pan-Cancer Analysis of Mutation Hotspots in Protein Domains Cell Systems. 1: 197-209. DOI: 10.1016/S0959-8049(16)61060-2  0.657
2014 Noor E, Bar-Even A, Flamholz A, Reznik E, Liebermeister W, Milo R. Pathway thermodynamics highlights kinetic obstacles in central metabolism. Plos Computational Biology. 10: e1003483. PMID 24586134 DOI: 10.1371/Journal.Pcbi.1003483  0.372
2013 Reznik E, Mehta P, Segrè D. Flux imbalance analysis and the sensitivity of cellular growth to changes in metabolite pools. Plos Computational Biology. 9: e1003195. PMID 24009492 DOI: 10.1371/Journal.Pcbi.1003195  0.403
2013 Reznik E, Chaudhary O, Segrè D. The average enzyme principle. Febs Letters. 587: 2891-4. PMID 23892076 DOI: 10.1016/J.Febslet.2013.07.032  0.598
2013 Reznik E, Kaper TJ, Segrè D. The dynamics of hybrid metabolic-genetic oscillators. Chaos (Woodbury, N.Y.). 23: 013132. PMID 23556969 DOI: 10.1063/1.4793573  0.641
2013 Reznik E, Watson A, Chaudhary O. The stubborn roots of metabolic cycles. Journal of the Royal Society, Interface / the Royal Society. 10: 20130087. PMID 23554346 DOI: 10.1098/Rsif.2013.0087  0.382
2013 Reznik E, Yohe S, Segrè D. Invariance and optimality in the regulation of an enzyme. Biology Direct. 8: 7. PMID 23522082 DOI: 10.1186/1745-6150-8-7  0.617
2012 Collins SB, Reznik E, Segrè D. Temporal expression-based analysis of metabolism. Plos Computational Biology. 8: e1002781. PMID 23209390 DOI: 10.1371/Journal.Pcbi.1002781  0.752
2010 Reznik E, Segrè D. On the stability of metabolic cycles. Journal of Theoretical Biology. 266: 536-49. PMID 20673772 DOI: 10.1016/J.Jtbi.2010.07.023  0.639
Show low-probability matches.